Robert D. Joffe, the former Presiding Partner of Cravath, Swaine & Moore
LLP, has died of cancer, according to a Firm spokesperson. He was 66
years old.
Mr. Joffe, who […]
Rimini Street, Inc., the leading third-party maintenance and support
provider for enterprise software, including Oracle Corporation’s
(NASDAQ: ORCL) Siebel, PeopleSoft, and JD Edwards software and SAP AG
(NYSE: SAP) software, today announced record annual […]
Biogen
Idec (NASDAQ: BIIB) today issued the following statement regarding
the United States (U.S.) Food and Drug Administration (FDA) approval of
AMPYRA™ (dalfampridine) to improve walking in patients with multiple
sclerosis (MS). This was demonstrated […]
Starbucks Corporation (Nasdaq: SBUX) announced today that it will enter
the ready-to-drink (RTD) coffee category in Europe, an approximately
US$550 million (EUR368 million) market. Starbucks also announced today
that it has signed an agreement […]
CIGNA International announced it will develop and offer individual
Private Medical Insurance (PMI) to respond to the emerging needs of
customers around the globe. CIGNA International – a world leader in
global life, accident […]
The Independent Director Committee (the “Committee”) of Alcon,
Inc. (NYSE: ACL)
today announced that it formally responded to the January 4 proposal
from Novartis AG (“Novartis”) to attempt to acquire the minority
[…]
Alvogen, Inc. (Alvogen), the U.S.-based pharmaceutical company,
today announced that it has expanded operations in Eastern Europe and
has opened an office in Bucharest, Romania. Alvogen Romania
primarily will focus on sales and marketing to support several new
[…]
Smartmatic, a leading supplier of security and election solutions, along
with partner Cross Match Technologies Inc. were selected by the
Secretaría de Gobernación de México (Secretariat of Governance, SEGOB)
to supply new technologies to […]
Celgene International Sàrl (NASDAQ: CELG) today announced that
the Intergroupe Francophone du Myelome and University Hospital of
Toulouse, the sponsor of the study, reported that the independent Data
and Safety Monitoring Committee, of the international Phase III,
[…]
Biogen Idec (NASDAQ: BIIB) announced today the submission of a marketing
authorization application (MAA) to the European Medicines Agency for
Fampridine Prolonged Release (Fampridine-PR) tablets, a novel oral
therapy for the improvement of walking […]